Antibody Therapeutics for Life

Notices

Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.
  • Written by Admin
  • Written date 2019-01-14 11:33:11
  • Inquire 1655

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine 

is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.

http://aprdl2018.com/speaker.html

 

 

Event: Asia Pharma R&D Leaders Summit 2018

 

Keynote : Clinical Development of Tanibirumab, Its IO combination and novel IO program

-- Tanibirumab in recurrent GBM phase IIa open labelled three arms multi-center trial in Australia

-- Rationale of Tanibirumab + anti-PD1 antibody combination trials for refractory tumous

-- Development of novel IO bispecific antibody

 

 

Presentation Date: Tuesday, April 18th, 2018

Presentation Time: 10:00 - 10:30 AM

Location: InterContinental Shanghai Pudong Hotel, CHINA

 

 

For investors attending the Asia Pharma R&D Leaders Summit 2018, please contact PharmAbcine Investor Relations to schedule a meeting with

management at sungwoo.kim@pharmabcine.com.

List





Prev Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited ...
Next Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited ...